Lv2
182 积分 2023-02-20 加入
Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?
6天前
已完结
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel
13天前
已完结
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
18天前
已完结
Identifying novel oncogenic RET mutations and characterising their sensitivity to RET-specific inhibitors
28天前
已关闭
Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer
1个月前
已完结
Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG/AMP guidelines
1个月前
已完结
The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library
1个月前
已完结
A novel acquired ALK F1245C mutation confers resistance to crizotinib in ALK-positive NSCLC but is sensitive to ceritinib
1个月前
已完结
Insights into the molecular alterations of PLAG1 and HMGA2 in the malignant phenotype acquisition in pleomorphic adenoma
1个月前
已完结
The Cancer Genome Atlas for uveal melanoma is predictive of patient outcomes
3个月前
已完结
皖公网安备34019202002308
